Direct Health and Medical Insurance Carriers (NAICS 524114): A U.S. Industry Primer

1. Overview

Direct health and medical insurance carriers are the companies that take in premiums, bear the financial risk of members' medical claims, and pay the doctors and hospitals. In plain terms, this is the "health insurance company" itself — Aetna, the Blue Cross Blue Shield plans, Kaiser Permanente, UnitedHealthcare — as opposed to the broker who sells the policy or the government agency that funds a public program. It is a regulated, risk-bearing business, not the whole health-care system.

Measured by the money it handles, it is one of the largest single industries in the U.S. economy. The U.S. Census Bureau's 2022 Economic Census put annual receipts for this industry code at roughly $1.30 trillion.[1] A large and growing share of that is taxpayer money flowing through private carriers via Medicare Advantage and managed Medicaid, not premiums paid only by individuals or employers — a distinction that shapes everything about how the sector earns and how it is regulated.

Why it matters to an investor of any kind: coverage demand is durable and tied to demographics and employment more than to the economic cycle, and the industry sits at the center of about $5.3 trillion of annual U.S. health spending.[7][8] But earnings are unusually sensitive to medical-cost trends, government payment policy, capital rules, and — right now — intense regulatory, legal, and political pressure (Sections 7 and 9).

Two very different ways in. The for-profit side is one of the most concentrated large-cap groups in any market: a handful of names — UnitedHealth Group, Elevance Health, CVS Health (Aetna), Cigna, Humana, Centene, Molina — are publicly traded and easy to own. But a very large slice of the industry is not investable through the stock market at all: the Blue Cross Blue Shield licensees are mostly nonprofit or mutual (member-owned), and Kaiser Permanente is a nonprofit that owns its own hospitals. Private-market capital reaches the sector mainly through the adjacent services layer — provider groups, technology, care management, and the pharmacy-benefit machinery the big carriers have bought up.

2. What it is and how it is structured

The North American Industry Classification System (NAICS) code 524114 covers establishments primarily engaged in directly underwriting and administering health and medical insurance policies — setting premiums, accepting the risk that claims exceed premiums, and paying providers. It includes commercial health insurers, group hospitalization and medical-service plans, and health maintenance organizations (HMOs) acting in their insurance capacity.[4]

Carriers reach members through several channels:

• Employer-sponsored commercial coverage, either fully insured (carrier bears risk) or self-funded (the employer bears the claims risk and the carrier provides administrative services only, or ASO).
• Individual and family plans, including Affordable Care Act (ACA) Marketplace coverage.
• Medicare Advantage, in which private plans are paid by the Centers for Medicare & Medicaid Services (CMS) to cover Medicare beneficiaries.
• Medicaid managed care, in which states pay private plans to manage covered populations.
• Medicare Supplement, dental, vision, behavioral-health, and other specialty products.

What it excludes (and where those dollars are counted instead):[4]

• Insurance agencies and brokerages — NAICS 524210 (and adjusters/agents, 524291). Firms that sell coverage on commission (eHealth, GoHealth, benefits brokers) but bear no claims risk.
• Third-party administration of insurance and pension funds — NAICS 524292. Pure administrators that process claims for a fee without taking risk.
• HMO medical centers — NAICS 621491. The clinics that deliver care, as opposed to the insurance function. (This is why an integrated system like Kaiser straddles several codes.)
• Reinsurance carriers — NAICS 524130, direct life carriers (524113), and employer-only health-and-welfare funds (525120).
• Government social insurance itself. Traditional fee-for-service Medicare and Medicaid, administered directly by the government, are not a private industry and are not in this code. But when the government hires a private carrier to run a Medicare Advantage or managed-Medicaid plan, that carrier's revenue is in 524114 — a crucial distinction for understanding the money (Section 5).

Ownership is unusually varied for so large an industry, and the federal file reports no ownership-form split, so none is claimed here as a percentage. The mix includes:

• For-profit, publicly traded: the seven large-cap names above, which dominate the headlines and the profits.
• Mutual / member-owned: Health Care Service Corporation (HCSC) — the Blue plans of Illinois, Texas, and three other states — the largest customer-owned health insurer in the country, with roughly $64 billion of premiums.[32] It expanded nationally by acquiring Cigna's Medicare businesses in 2025.[28]
• Nonprofit: many of the independent Blue Cross Blue Shield (BCBS) licensees (Florida Blue/GuideWell, Blue Shield of California, Highmark, CareFirst, Horizon), plus Kaiser Permanente, a nonprofit integrated system that both insures roughly 12.6 million members and owns the hospitals and employs the doctors.[32] The BCBS Association is not a single insurer but a federation of independent, locally operated plans.[33]
• Provider-sponsored regional plans: UPMC Health Plan, Geisinger, and similar hospital-owned insurers.

So the "industry" is a mix of Wall Street giants and large nonprofit institutions that will never appear in a brokerage account.

3. How big it is

Federal figures for NAICS 524114. Receipts and concentration are from the 2022 Economic Census; employment and payroll are from 2023 County Business Patterns (CBP). These are different vintages and should not be read as a single-year financial statement.

The Small Business Administration (SBA) threshold is a federal-program eligibility line, not an estimate of typical carrier size. The concentration numbers deserve a pause: an HHI of 649 looks unconcentrated at the national level (below the 1,000 line the antitrust agencies treat as "unconcentrated"), but that is misleading — health insurance is bought in state and metro markets, where one or two carriers often hold 50–70% share. National statistics wash that out (Section 8).

Three caveats on the size figures:

1. What's counted, and what isn't. The Economic Census and CBP primarily capture establishments with paid employees; CBP excludes most government workers, the self-employed, businesses without employees, and firms with no employer identification number, and the Economic Census generally excludes government-owned establishments.[5][6] So the data describe payroll-based carrier establishments, not every organization involved in coverage; the federal sources give no undercount estimate.

2. The $1.30 trillion understates the claims the industry actually handles. A growing share of employer coverage is self-funded: under an ASO arrangement the carrier books only the administrative fee as revenue, not the premium-equivalent, even though it processes the full claims volume. Total U.S. health spending reached about $5.3 trillion in 2024 (18.0% of gross domestic product, GDP, up 7.2%), of which private health insurance was about $1.64 trillion (31%), and spending is estimated near $5.7 trillion in 2025[7][8][9] — far above this industry's receipts, because much of it flows through government fee-for-service, out-of-pocket payments, and self-funded plans that never register as carrier premium.

3. At the company level the discrepancy runs the other way. The consolidated revenue of the big listed carriers (Section 4) exceeds their share of these insurance receipts, because those companies also own pharmacy-benefit managers, pharmacies, and physician groups whose revenue lands in other industry codes. UnitedHealth's ~$400 billion is not $400 billion of insurance premium — the Census figure isolates the insurance-carrier activity; the ticker measures the whole conglomerate.

Finally, an honesty note: the federal file for this code does not report aggregate premiums, claims, enrollment, medical loss ratio, underwriting profit, or investment income. CMS national-spending figures are context, not a substitute for those missing industry-specific measures.

4. The investable universe

Public equity access is narrow but liquid. Seven large-cap carriers make up the bulk of the for-profit industry; one advocacy tally put their combined 2025 revenue on the order of $1.7 trillion, with roughly $54 billion of profit.[31] Revenue below is consolidated — it includes pharmacy, PBM, and care-delivery businesses well beyond pure insurance — so ticker-level companies are imperfect proxies for NAICS 524114.

*Consolidated group revenue; includes non-insurance segments. Sources: company Form 10-K filings and Fortune 500 healthcare rankings.[34][35]

Membership figures are useful but definition-dependent (medical members vs. "people served," commercial vs. government), so treat cross-company enrollment comparisons with care. Broadly, Elevance and UnitedHealthcare each serve on the order of tens of millions of medical members, while Humana's book is concentrated in Medicare Advantage and Centene's and Molina's in Medicaid.

Smaller / newer public plays include Oscar Health (OSCR) and Alignment Healthcare (ALHC) — tech-enabled, focused on the ACA Marketplace and Medicare Advantage respectively — and Clover Health (CLOV). Note that several healthcare-insurance-adjacent tickers are not carriers: eHealth (EHTH) and GoHealth (GOCO) are brokers (NAICS 524210), and HealthEquity (HQY) administers health savings accounts.

Major owners you cannot buy on an exchange are, collectively, as large as the public group: the Blue Cross Blue Shield system (independent licensees which, combined, would be the country's largest insurer),[33] mutual HCSC,[32] nonprofit Kaiser Permanente (~12.6M members),[32] GuideWell/Florida Blue, Highmark, CareFirst, and provider-sponsored regional plans. If you want exposure to these, the stock market does not offer it directly.

5. How the money works

At its core a health carrier is a spread business on medical costs, and the metrics are specific to this industry — not the "combined ratio and float" of property-casualty insurers, and not the net-interest-margin language of banks. The basic model:

Premiums and government payments + investment income − medical benefits − operating costs − taxes and assessments − reserve changes = earnings.

Carriers price policies before claims are known, negotiate provider rates, manage utilization, estimate liabilities, and hold reserves. What matters most:

• Membership (covered lives) and PMPM. Revenue is members × premium per member per month (PMPM). Growth comes from adding members and from rate increases. Government programs generally pay PMPM, adjusted for member risk, geography, quality, and program rules.

• Medical loss ratio (MLR), also called the medical cost or benefit ratio. The share of premium paid out as medical claims — the single most-watched number; the carrier keeps the gap between premium and (claims + admin) as underwriting margin. Uniquely, the ACA sets a floor: insurers must spend at least 80% of premium on care in the individual and small-group markets and 85% in the large-group market, or rebate the difference; Medicare Advantage and Part D plans also face an 85% minimum, with financial and enrollment sanctions for failure.[19][20] So a health insurer cannot simply widen its margin without limit — regulation caps how little of the premium it may pay out.

• Medical cost trend. The variable cost is claims, driven by unit price × utilization. It has been running hot: commercial medical costs have risen ~8%+ a year since 2023, and the Medicare Advantage combined MLR hit a five-year high near 90.3% in 2025, with claims (+15.5%) outrunning premiums (+14.3%).[21] Elevated utilization, not just price, has squeezed margins across nearly every line.

• Risk-based vs. fee-based revenue. In fully insured business the carrier bears claims risk. In ASO/self-funded business it takes no claims risk and earns only an administrative fee — lower revenue but higher-margin, far less capital-intensive, and steadier because it doesn't move with medical trend.

• Government-program revenue and risk adjustment. For Medicare Advantage and managed Medicaid, payment scales up for sicker members (higher "risk scores") under risk adjustment — both an economic engine and a legal minefield (Sections 7 and 9). MA plans also earn bonuses tied to CMS Star Ratings for quality.

• Reserves (IBNR) and investment income. Carriers hold reserves for claims incurred but not reported (IBNR); reserve adequacy drives earnings quality, and inadequate reserves can reverse prior-period profit. Because health claims are paid quickly (a "short tail"), the investable "float" is small relative to premium — so, unlike life or property-casualty insurers, health carriers earn comparatively little from investing premiums before paying claims. The money is made on underwriting and services, not on the float.

• Capital, not just income. A carrier can look profitable on the income statement yet be undercapitalized for the risk it assumes; risk-based capital (RBC) rules gate that (Section 7). Analyze the statutory insurance subsidiaries, not only the parent's consolidated accounts.

• The services flywheel. The biggest earnings story of the last decade is vertical integration: UnitedHealth's Optum, CVS's Caremark, and Cigna's Evernorth. The three largest pharmacy-benefit managers (PBMs) — the middlemen who negotiate drug prices and process pharmacy claims — handle roughly 80% of U.S. prescription claims and belong to these carriers.[26] Increasingly, profit comes from the PBM, pharmacy, and owned physician groups rather than from underwriting itself.

How owners get paid. For-profit carriers return cash through dividends and (large) buybacks, constrained by statutory capital rules. Mutuals like HCSC retain surplus for policyholders; nonprofits and Kaiser reinvest surplus into the enterprise and community benefit. There are no dividends to clip from the nonprofit majority of the industry.

6. What drives demand

Demand is unusually stable, but its composition shifts with policy and demographics:

• Employment. Employer-sponsored insurance is still the largest source of coverage — about 53.8% of the population, roughly 154 million non-elderly people.[10] Job growth expands the commercial book; layoffs shrink it (and push people toward Medicaid or the Marketplace).

• Aging into Medicare — and the shift to Medicare Advantage. The industry's growth engine. The U.S. population age 65+ rose 3.1% to 61.2 million in 2024.[11] Roughly 34–36 million people are now in privately run Medicare Advantage plans — over half of eligible Medicare beneficiaries: KFF puts it at 34.4 million (55% of eligible beneficiaries, and 54% of Medicare spending) in 2025,[12] while CMS projected 35.7 million, about 51% of total Medicare enrollment[13] (the shares differ because of different denominators). Every retiring boomer is a potential new private-plan member — though older members also carry higher claims risk.

• Medicaid and the "unwinding." Managed Medicaid is a huge private book — more than 70% of Medicaid and Children's Health Insurance Program (CHIP) beneficiaries get care through managed-care plans[14] — but enrollment is policy-driven. After pandemic-era continuous coverage ended in 2023, states removed roughly 13 million people; Medicaid/CHIP enrollment fell to about 77.7 million by mid-2025, down ~18% from its peak.[15] Enrollment volume is a direct revenue lever for Centene, Molina, and Medicaid-heavy plans, and exposes them to state rebids and rate adequacy.

• The ACA Marketplace and subsidies. Individual-market enrollment roughly doubled under enhanced federal premium subsidies, reaching 22.3 million in 2025,[16] and CMS reported 23.1 million plan selections for the 2026 open-enrollment period.[17] But the enhanced subsidies lapsed after 2025: KFF projects average out-of-pocket premiums more than doubling (~+114%) and effectuated 2026 enrollment falling materially — possibly toward 17.5 million or lower — as healthier members drop out.[16][18] Because open-enrollment plan selections and effectuated (paying) enrollment can diverge sharply, the 23.1M headline overstates the coverage likely to persist. This is the single biggest near-term demand swing in the sector, and it raises the share of sicker enrollees who remain (adverse selection).

• Health-care spending, complexity, and innovation. National health expenditures of ~$5.3 trillion (18.0% of GDP) in 2024[7] underpin the whole book. Chronic disease, specialty drugs, behavioral health, hospital consolidation, and demand for home-based care all raise both the need for coverage and the difficulty of pricing it — with new high-cost therapies (notably GLP-1 weight-loss and diabetes drugs) adding fresh cost pressure.

7. Regulation

Health insurance is regulated at two levels, and knowing which applies to which product is essential.

State insurance departments are the primary regulators of fully insured products, under the McCarran-Ferguson Act (1945), which leaves the "business of insurance" to the states.[22] States license carriers, review premium rates, approve changes in control, and enforce solvency through the National Association of Insurance Commissioners' (NAIC) risk-based capital (RBC) framework — capital scaled to risk, with regulatory intervention if it falls too low.[23] RBC and rate review limit how aggressively a carrier can price for margin or push capital up to shareholders.

Federal law governs the big public programs and self-funded plans. CMS sets Medicare Advantage and Part D rates, risk-adjustment models, Star Ratings, and the MLR rebate, and oversees ACA Marketplace rules (guaranteed issue, essential benefits, rate review, the 80/20 rule). Medicaid managed-care capitation rates must be developed on actuarially sound principles under CMS guidance. The Employee Retirement Income Security Act (ERISA) governs self-funded employer plans and largely preempts state regulation of them, while fully insured plans remain under state law.

Two regulatory items are moving the numbers right now:

1. The V28 risk-adjustment model. CMS is phasing in a revised Medicare Advantage risk model (CMS-HCC "V28") that cuts the number of payable diagnosis codes and lowers average risk scores by roughly 3%, reaching 100% V28 in 2026.[27] This directly reduces per-member payments to MA plans and is a structural headwind.

2. Antitrust and PBM scrutiny. In 2021 the Competitive Health Insurance Reform Act repealed health insurers' long-standing federal antitrust exemption under McCarran-Ferguson.[24] The Federal Trade Commission (FTC) has accused the big-three PBMs of marking up drugs and steering patients to affiliated pharmacies — one FTC analysis found about $7.3 billion in specialty-generic markups over 2017–2022[25] — and there is bipartisan legislative interest in forcing insurers to divest their PBMs. On mergers, the Department of Justice (DOJ) required broad divestitures to settle its challenge to UnitedHealth's acquisition of Amedisys, reflecting concern about vertical integration between insurance and care delivery.[29]

8. Competitive dynamics and consolidation

Competition turns on five advantages: provider-network breadth and negotiated unit costs; actuarial and risk-adjustment data; distribution (employers, brokers, government contracts, digital); administrative scale in claims, compliance, and technology; and integrated pharmacy, provider, behavioral-health, and home-care capabilities.

The defining trend is vertical integration — rather than compete only on insurance, the largest carriers have bought the businesses on either side of the claim:

• UnitedHealth / Optum — the largest carrier is now also one of the largest employers of physicians, and owns the largest PBM (OptumRx) plus a major claims clearinghouse.
• CVS / Aetna / Caremark — insurer, PBM, and retail-pharmacy footprint under one roof.
• Cigna / Evernorth / Express Scripts — insurance plus the second-largest PBM.

The logic is to capture margin across the whole "healthcare dollar" and smooth the volatility of pure underwriting with steadier services income. The result is an oligopoly in the for-profit segment (national CR4 of 44%,[1] far higher within individual states) and a market where three carriers' PBMs touch ~80% of prescriptions.[26] As noted, the national HHI of 649 (below the 1,000 "unconcentrated" line) is only a rough screen; competition is local and product-specific, and a code-level HHI does not measure any single Medicaid contract, employer market, provider network, or Medicare Advantage county.[1]

Consolidation continues both horizontally and vertically: HCSC completed its acquisition of Cigna's Medicare and CareAllies businesses in 2025,[28] while national for-profits keep absorbing regional and provider-sponsored plans and the nonprofit Blues and Kaiser hold their regional strongholds. Barriers to entry are high — network contracting, regulatory capital, brand, and data scale all favor incumbents — which is why venture-backed "insurtech" entrants (Oscar, Bright Health, Clover, Alignment) have found the economics brutally hard, with Bright Health exiting the insurance business entirely. The strategic test is not simply whether a carrier is larger, but whether scale improves provider economics and care management without weakening consumer choice or inviting antitrust intervention.

9. Risks

• Medical cost trend — the core risk. When utilization or unit costs run ahead of premiums already locked in for the year, margins compress fast, as they did across Medicare Advantage in 2024–2025. Carriers reprice annually but are always one bad trend estimate away from an earnings miss.

• Government dependence and reimbursement risk. With Medicare Advantage and managed Medicaid now a majority of many carriers' revenue — for UnitedHealthcare a large majority is taxpayer-funded[31] — a CMS rate cut, the V28 model, Star-Rating downgrades, or state Medicaid budget squeezes hit the top line directly and faster than carriers can reprice.

• Reserve risk. Claims arrive after policies are written; inadequate IBNR reserves can reverse prior-period earnings.

• Legal and political risk — now acute. In 2025 UnitedHealth confirmed civil and criminal DOJ investigations into its Medicare Advantage billing (whether it inflated diagnoses to raise risk-adjustment payments), suspended financial guidance amid surging medical costs, changed CEOs, and saw its stock fall more than 42% over the year.[30] The December 2024 killing of a UnitedHealthcare executive crystallized intense public hostility toward the industry's coverage-denial and prior-authorization practices.

• Regulatory reform of the PBM/vertical model. Legislation to force PBM divestiture, or to cap PBM practices, would strike at the industry's main profit engine.

• Subsidy and coverage cliffs. The expiration of enhanced ACA subsidies is expected to shrink the Marketplace book and worsen the risk pool through adverse selection in 2026.[16][18]

• Capital, provider-bargaining, and integration risk. RBC and rate review constrain capital returns; consolidated hospital and physician systems can demand higher rates; and stitching insurers together with pharmacy, provider, and technology arms creates complex incentives, execution risk, and antitrust exposure.

• Ownership and liquidity risk. The nonprofit and mutual majority of the industry has strong local franchises but no publicly traded equity, limited disclosure, and no ordinary exit route.

10. How to invest, and the outlook

Public-market routes. The direct way in is the large-cap carriers — UNH, ELV, CVS, CI, HUM, CNC, MOH — which trade with the visible metrics of the sector (share price, dividend yield, and earnings multiples that have historically sat at a modest discount to the broad market given the political overhang). Diversified exposure is available through managed-care and healthcare ETFs, and every broad healthcare fund carries heavy weightings in these names. Separate the insurance business from the adjacent pharmacy/provider/services operations, and watch each carrier's MLR trend, membership growth by product and state (commercial vs. MA vs. Medicaid vs. Marketplace), Medicaid rebids and MA bid discipline, Star Ratings, risk-adjustment exposure, reserve development, and statutory RBC and parent-company capital allocation. Revenue growth alone is a weak signal — a carrier can grow fast while losing money if medical costs or contract pricing deteriorate; value on normalized earnings, cash generation, and margin durability. A key nuance: the "insurance" thesis is now really a bet on the services flywheel (Optum, Caremark, Evernorth) as much as on underwriting. Investment-grade bonds of the listed carriers offer a lower-risk fixed-income route.

Private-market routes. Because the Blues, HCSC, and Kaiser are mutual or nonprofit, private investors generally cannot buy the carriers themselves. Direct acquisition of a regional insurer requires state change-of-control approval, capital commitments, and actuarial/reserve diligence; private credit to regulated insurance groups is another avenue. More commonly, exposure comes through the surrounding ecosystem private equity and venture capital have concentrated in: value-based provider groups and physician platforms, care-management and utilization technology, PBM/pharmacy-services assets, risk-adjustment and claims software, and Medicare Advantage provider-enablement companies.

Outlook. CMS projects national health expenditures to keep growing faster than GDP through 2034, with private health insurance spending rising about 5.0% a year — a favorable long-term demand backdrop.[7] But near-term earnings will stay cyclical around: whether medical cost trend normalizes or stays elevated; the full-year 2026 hit from the V28 risk model at 100%; how far the ACA Marketplace book shrinks now that enhanced subsidies have lapsed; the outcome of the DOJ and FTC actions and any PBM-divestiture legislation; and the pace of Medicare Advantage growth as it matures past the halfway mark of all Medicare beneficiaries. The long-term tailwind — an aging population steadily converting into privately managed Medicare lives — remains intact, but this is, for now, a sector whose demographic growth story is running headlong into a cost, regulatory, and reputational reckoning. The central test for any operator is whether it can turn scale into lower risk-adjusted medical costs without sacrificing network quality, regulatory standing, or capital flexibility.

---

Sources

1. U.S. Census Bureau. 2022 Economic Census — Concentration of Largest Firms and receipts, NAICS 524114 (Direct Health and Medical Insurance Carriers). 2025. https://data.census.gov/table/ECNSIZE2022.EC2200SIZECONCEN
2. U.S. Census Bureau. County Business Patterns 2023 — NAICS 524114 (employment, establishments, payroll). 2025. https://data.census.gov/table/CBP2023.CB2300CBP
3. U.S. Small Business Administration. Table of Small Business Size Standards (NAICS 524114), effective March 2023. 2023. https://www.sba.gov/document/support-table-size-standards
4. U.S. Census Bureau. 2022 NAICS Manual (definition and exclusions for 524114). 2022. https://www.census.gov/naics/reference_files_tools/2022_NAICS_Manual.pdf
5. U.S. Census Bureau. County Business Patterns Methodology (coverage exclusions). 2026. https://www.census.gov/programs-surveys/cbp/technical-documentation/methodology.html
6. U.S. Census Bureau. 2022 Economic Census Methodology. 2025. https://www.census.gov/programs-surveys/economic-census/year/2022/technical-documentation/methodology.html
7. Centers for Medicare & Medicaid Services. National Health Expenditure Fact Sheet (NHE $5.3T / 18.0% of GDP; private health insurance $1.6446T; projections through 2034). 2026. https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data/nhe-fact-sheet
8. Health Affairs. National Health Care Spending Increased 7.2 Percent in 2024 as Utilization Remained Elevated. 2025. https://www.healthaffairs.org/doi/10.1377/hlthaff.2025.01683
9. Healthcare Dive. US health spending spikes to $5.7T in 2025, though growth should moderate, CMS finds. 2025. https://www.healthcaredive.com/news/us-health-spending-spikes-57t-2025/823660/
10. U.S. Census Bureau. Health Insurance Coverage in the United States: 2024 (P60-288). 2025. https://www.census.gov/library/publications/2025/demo/p60-288.html
11. U.S. Census Bureau. Vintage 2024 Population Estimates (population 65+ = 61.2 million). 2025. https://www.census.gov/newsroom/press-releases/2025/older-adults-outnumber-children.html
12. KFF. Medicare Advantage in 2026: Enrollment Update and Key Trends. 2026. https://www.kff.org/medicare/medicare-advantage-in-2026-enrollment-update-and-key-trends/
13. Centers for Medicare & Medicaid Services. Medicare Advantage and Medicare Prescription Drug Programs to Remain Stable in 2025 (35.7M projected enrollment). 2024. https://www.cms.gov/newsroom/press-releases/medicare-advantage-medicare-prescription-drug-programs-remain-stable-cms-implements-improvements
14. Centers for Medicare & Medicaid Services. Medicaid and CHIP Managed Care Access, Finance, and Quality Final Rule. 2024. https://www.cms.gov/newsroom/fact-sheets/medicaid-and-childrens-health-insurance-program-managed-care-access-finance-and-quality-final-rule
15. KFF. Medicaid Enrollment and Unwinding Tracker. 2025. https://www.kff.org/medicaid/medicaid-enrollment-and-unwinding-tracker/
16. KFF. What We Know So Far About 2026 ACA Marketplace Enrollment, Premiums, and Deductibles. 2026. https://www.kff.org/affordable-care-act/what-we-know-so-far-about-2026-aca-marketplace-enrollment-premiums-and-deductibles/
17. Centers for Medicare & Medicaid Services. Health Insurance Exchanges 2026 Open Enrollment Report (23.1M plan selections). 2026. https://www.cms.gov/newsroom/press-releases/exchange-coverage-remains-near-record-high-23-1-million-enroll-2026-reflecting-continued-strength
18. Congress.gov (Congressional Research Service). Enhanced Premium Tax Credit and 2026 Exchange Premiums: FAQ (R48290). 2025. https://www.congress.gov/crs-product/R48290
19. Centers for Medicare & Medicaid Services. Medical Loss Ratio (80/20 and 85/15 rules). 2026. https://www.cms.gov/marketplace/private-health-insurance/medical-loss-ratio
20. Centers for Medicare & Medicaid Services. Medicare Advantage and Part D Medical Loss Ratio. 2026. https://www.cms.gov/medicare/health-drug-plans/medical-loss-ratio
21. Medicare Market Insights. Medicare Advantage Loss Ratios: 2025 Market Review. 2026. https://www.medicaremarketinsights.com/p/medicare-advantage-loss-ratios-2025-market-review
22. NAIC. McCarran-Ferguson Act. 2026. https://content.naic.org/insurance-topics/mccarran-ferguson-act
23. NAIC. Risk-Based Capital. 2026. https://content.naic.org/insurance-topics/risk-based-capital
24. Sidley Austin LLP. McCarran-Ferguson Act Amended to Repeal the Antitrust Exemption for the "Business of Health Insurance" (Competitive Health Insurance Reform Act of 2020). 2021. https://www.sidley.com/en/insights/newsupdates/2021/01/mccarran-ferguson-act-amended-to-repeal-long-standing-federal-antitrust-exemption
25. U.S. Federal Trade Commission. Second Interim Staff Report on Prescription Drug Middlemen (specialty-generic markups, 2017–2022). 2025. https://www.ftc.gov/reports
26. IntuitionLabs. The Big 3 PBMs: An Analysis of Market Share & Dominance (~80% of prescription claims). 2025. https://intuitionlabs.ai/articles/big-three-pbms-market-share
27. MedInsight. Medicare Advantage 2026: Breaking down the new CMS-HCC V28 risk model. 2025. https://medinsight.com/healthcare-data-analytics-resources/blog/medicare-advantage-2026-cms-hcc-v28-impact/
28. Health Care Service Corporation. HCSC Completes the Acquisition of The Cigna Group's Medicare and CareAllies Businesses. 2025. https://www.hcsc.com/newsroom/news-releases/2025/completes-cigna-medicare-acquisition
29. U.S. Department of Justice. Court Approves Justice Department's Settlement in UnitedHealth Group / Amedisys Merger. 2025. https://www.justice.gov/opa/pr/court-approves-justice-departments-settlement-unitedhealth-group-and-amedisys-merger
30. CNBC. UnitedHealth facing DOJ investigation over Medicare billing; shares down more than 42%. 2025. https://www.cnbc.com/2025/07/24/unitedhealthcare-doj-investigation-medicare-billing.html
31. HealthcareUncovered (Wendell Potter). 2025: Big Insurance's $1.7 Trillion Year (advocacy analysis; aggregate revenue/profit and government-program revenue share). 2026. https://healthcareuncovered.substack.com/p/2025-big-insurances-17-trillion-year
32. ValuePenguin / Definitive Healthcare. Largest Health Insurance Companies (Kaiser Permanente ~12.6M members; HCSC structure and premiums). 2025. https://www.valuepenguin.com/largest-health-insurance-companies
33. Blue Cross Blue Shield Association. The Blue Cross and Blue Shield System. 2026. https://www.bcbs.com/about-us/blue-cross-blue-shield-system
34. Becker's Hospital Review / Becker's Payer Issues. Fortune 500 top healthcare companies (2024 revenue) and largest insurers by enrollment. 2025. https://www.beckershospitalreview.com/rankings-and-ratings/fortune-500s-top-25-healthcare-companies/
35. U.S. Securities and Exchange Commission (EDGAR). Company Form 10-K filings — UnitedHealth Group, Elevance Health, The Cigna Group, CVS Health, Humana, Centene, Molina, Oscar Health, Alignment Healthcare. 2026. https://www.sec.gov/cgi-bin/browse-edgar